|
rdfs:label
|
"Glaxo Wellcome"@fr
"Glaxo Wellcome"@de
"Glaxo Wellcome"@en
"Glaxo Wellcome"@en-ca
"Glaxo Wellcome"@en-gb
"Glaxo Wellcome"@lt
"Glaxo Wellcome"@nb
"Glaxo Wellcome"@nl
"Glaxo Wellcome"@sv
|
|
schema:description
|
"Unternehmen"@de
"brittiskt företag"@sv
"company"@en
"şirket"@tr
"компанія"@uk
"شركة"@ar
|
|
schema:dateModified
|
"2026-08-22T04:28:00+00:00"^^xsd:dateTime
|
|
schema:version
|
2534591929
|
|
wikibase:identifiers
|
18
|
|
wikibase:sitelinks
|
2
|
|
wikibase:statements
|
24
|
|
p:P13092
|
wd:statement/Q911693-0FE4E260-E042-4528-A841-2FB91B047EFE
|
|
p:P13591
|
wd:statement/Q911693-C200ACCF-A5F7-4347-9421-041BE3BC512B
|
|
p:P1365
|
wd:statement/Q911693-8ca80c51-4133-294c-6560-b029d60ad8c9
|
|
wd:statement/Q911693-91f16944-4680-2370-02b2-715298b52070
|
|
p:P1366
|
wd:statement/Q911693-420109ea-4d62-935a-6f15-2550c2af10f6
|
|
p:P14177
|
wd:statement/Q911693-B9083527-E2B8-43CC-806C-4B4EA6EE180D
|
|
p:P14750
|
wd:statement/Q911693-FBDB11E7-29C2-4E55-B1D4-E72F2C7B0A27
|
|
p:P17
|
wd:statement/Q911693-9A5D24C4-178F-45D5-B9C5-3A98306179AB
|
|
p:P213
|
wd:statement/Q911693-EA8088EC-0450-4595-87D6-381465E46AD4
|
|
p:P214
|
wd:statement/Q911693-0655FA42-5698-4D55-8B90-8E49D41A15E3
|
|
p:P244
|
wd:statement/Q911693-22D61A46-111B-4FAE-A178-D159FC589D9A
|
|
p:P268
|
wd:statement/Q911693-97F4501C-D1BF-4C41-B802-DA5D816C770D
|
|
p:P269
|
wd:statement/Q911693-FB9A13BC-2901-4BC3-9B8E-7370B638148B
|
|
p:P31
|
wd:statement/Q911693-D1F2B1B2-322F-489E-9BC2-6533EF3270BE
|
|
p:P3987
|
wd:statement/Q911693-4D8833CD-449F-40D1-867C-799EF4F65AA8
|
|
p:P4389
|
wd:statement/Q911693-092e2a0f-4840-a2b3-ba29-a9f7aaa3a7ad
|
|
p:P4527
|
wd:statement/Q911693-4304B008-6DA8-4BE3-86F0-54ECC2A2B9C4
|
|
p:P576
|
wd:statement/Q911693-4dba1156-4bce-f382-72ed-492a9074cefc
|
|
p:P646
|
wd:statement/Q911693-3CA812CD-4A4A-46F8-B87C-15C482B06C84
|
|
p:P691
|
wd:statement/Q911693-74ECB7F6-9236-4ACC-BDB1-F7F83D86C1CB
|
|
wd:statement/Q911693-F2FD362F-9788-4F7B-A0FA-3C4970C92EB7
|
|
p:P8168
|
wd:statement/Q911693-270CDA04-7D70-4A6F-B023-349D895C4370
|
|
p:P9322
|
wd:statement/Q911693-24E3C76B-25D0-4AD7-9C23-07670A83F00D
|
|
wd:statement/Q911693-4075759F-F6BD-47E4-AC7B-8CE63F2D4725
|
|
p:direct-normalized/P214
|
<http://viaf.org/viaf/144197849>
|
|
p:direct-normalized/P244
|
<http://id.loc.gov/authorities/names/n97800313>
|
|
p:direct-normalized/P268
|
<http://data.bnf.fr/ark:/12148/cb125670603#about>
|
|
p:direct-normalized/P269
|
<http://www.idref.fr/034835555/id>
|
|
p:direct-normalized/P4527
|
<http://data.parliament.uk/terms/36600>
|
|
p:direct-normalized/P8168
|
<https://database.factgrid.de/entity/Q405701>
|
|
wdt:P13092
|
"K000361749"
|
|
wdt:P13591
|
"group/a9c71dce-80bc-4a71-bdcc-c94800b4dfea"
|
|
wdt:P1365
|
Burroughs Wellcome & Company
|
|
Glaxo
|
|
wdt:P1366
|
GSK
|
|
wdt:P14177
|
"nlk20020121822"
|
|
wdt:P14750
|
"83B6-0DF6-FB6D-0B39-7ADD"
|
|
wdt:P17
|
United Kingdom
|
|
wdt:P213
|
"000000011431958X"
|
|
wdt:P214
|
"144197849"
|
|
wdt:P244
|
"n97800313"
|
|
wdt:P268
|
"125670603"
|
|
wdt:P269
|
"034835555"
|
|
wdt:P31
|
business
|
|
wdt:P3987
|
"301071"
|
|
wdt:P4389
|
"cp3395"
|
|
wdt:P4527
|
"36600"
|
|
wdt:P576
|
"2000-01-01T00:00:00+00:00"^^xsd:dateTime
|
|
wdt:P646
|
"/m/03m6rgg"
|
|
wdt:P691
|
"nlk20020121822"
|
|
"nlk20020121823"
|
|
wdt:P8168
|
"Q405701"
|
|
wdt:P9322
|
"0271182-Glaxo-Wellcome"
|
|
"0271183-Glaxo-plc"
|